Ting-Yuan Chang

Dr. Ting-Yuan Chang is currently an Attending Physician at Kaohsiung Medical University Chung-Ho Memorial Hospital. She received her medical degree from Kaohsiung Medical University, where she also completed her residency in Pediatrics. Dr. Chang subsequently concluded a fellowship in Pediatric Nephrology at National Taiwan University Children's Hospital. Her clinical practice and research focus on pediatric nephrology, comprehensive renal care, and pediatric continuous renal replacement therapy.

20th September 2026 Sunday

Time	Session

14:00 15:30	Workshop 2 - Session F Pediatric Extracorporeal Therapies: From Basics to Advanced Clinical Challenges Hsin-Hui Wang Moderator I-Jung Tsai Moderator Beyond Renal Replacement: Advanced Extracorporeal Blood Purification in Pediatric Sepsis Station 2 Core Decisions: Modality Selection (CVVH / CVVHD / CVVHDF) & Prescription Shotaro Matsumoto Speaker The Ultimate Support: Heart-Lung-Kidney Crosstalk and ECMO-CRRT Integration in PediatricsCore Decisions: Modality Selection (CVVH / CVVHD / CVVHDF) & Prescription Station 3 The Perfect Balance: Regional Citrate Anticoagulation (RCA) in Practice Hou-Xaun Emma Huang Speaker The Perfect Balance: Regional Citrate Anticoagulation (RCA) in Practice Station 4 Advanced Purification: Therapeutic Plasma Exchange (TPE) Concepts & Challenges Jhao-Jhuang Ding Speaker Advanced Purification: Therapeutic Plasma Exchange (TPE) Concepts & ChallengesTherapeutic plasma exchange (TPE) is the most widely used therapeutic apheresis modality in critically ill children, yet it remains technically demanding and conceptually distinct from diffusion- and convection-based renal replacement. This hands-on station reviews the core principles of TPE—one-compartment kinetics, the rationale for a 1.0–1.5 plasma-volume exchange, and how molecular size and protein binding determine what TPE can and cannot remove—and links them to evidence-based indications from the ASFA guidelines relevant to pediatric practice (e.g., thrombotic microangiopathies, ANCA-associated and anti-GBM disease, autoimmune neurologic disease, and liver failure). Emphasis is placed on the practical challenges unique to children: vascular access and circuit sizing, blood priming for small patients, choice of replacement fluid (albumin vs. fresh frozen plasma), anticoagulation with citrate versus heparin, and the recognition and management of complications such as hypocalcemia, coagulopathy, and hemodynamic instability. Through short clinical cases, participants will practice prescribing and troubleshooting TPE at the bedside. By the end of this station, participants will be able to: 1. Explain the pharmacokinetic basis of TPE and justify the prescribed exchange volume and frequency. 2. Select appropriate ASFA-supported indications for TPE in pediatric AKI/critical-care settings and distinguish TPE from CRRT modalities. 3. Prescribe TPE for a child—vascular access, replacement fluid, anticoagulation—and adjust for body size. 4. Recognize and manage common complications (hypocalcemia, coagulopathy, hypotension, reactions). Station 1 The Critical Initiation: Circuit Priming & Hemodynamic Management Ting-Yuan Chang Speaker The Critical Initiation: Circuit Priming & Hemodynamic ManagementThis workshop addresses the critical first steps of initiating continuous kidney replacement therapy (CKRT) in pediatric patients. Topics include selecting an appropriate CKRT machine, determining hemofilter size, and designing the extracorporeal circuit. Special emphasis is placed on preventing hemodynamic instability during blood priming and circuit initiation, including calculation of the patient's circulating blood volume relative to the extracorporeal volume to avoid hypovolemic shock from excessive extracorporeal blood sequestration. Participants will learn practical decision-making frameworks for safe circuit priming strategies tailored to children of different body sizes. Room 2

Time

Session

14:00

15:30

Workshop 2 - Session F

Pediatric Extracorporeal Therapies: From Basics to Advanced Clinical Challenges

Hsin-Hui Wang Moderator

I-Jung Tsai Moderator Beyond Renal Replacement: Advanced Extracorporeal Blood Purification in Pediatric Sepsis

Station 2 Core Decisions: Modality Selection (CVVH / CVVHD / CVVHDF) & Prescription

Shotaro Matsumoto Speaker The Ultimate Support: Heart-Lung-Kidney Crosstalk and ECMO-CRRT Integration in PediatricsCore Decisions: Modality Selection (CVVH / CVVHD / CVVHDF) & Prescription
Station 3 The Perfect Balance: Regional Citrate Anticoagulation (RCA) in Practice

Hou-Xaun Emma Huang Speaker The Perfect Balance: Regional Citrate Anticoagulation (RCA) in Practice
Station 4 Advanced Purification: Therapeutic Plasma Exchange (TPE) Concepts & Challenges

Jhao-Jhuang Ding Speaker Advanced Purification: Therapeutic Plasma Exchange (TPE) Concepts & ChallengesTherapeutic plasma exchange (TPE) is the most widely used therapeutic apheresis modality in critically ill children, yet it remains technically demanding and conceptually distinct from diffusion- and convection-based renal replacement. This hands-on station reviews the core principles of TPE—one-compartment kinetics, the rationale for a 1.0–1.5 plasma-volume exchange, and how molecular size and protein binding determine what TPE can and cannot remove—and links them to evidence-based indications from the ASFA guidelines relevant to pediatric practice (e.g., thrombotic microangiopathies, ANCA-associated and anti-GBM disease, autoimmune neurologic disease, and liver failure). Emphasis is placed on the practical challenges unique to children: vascular access and circuit sizing, blood priming for small patients, choice of replacement fluid (albumin vs. fresh frozen plasma), anticoagulation with citrate versus heparin, and the recognition and management of complications such as hypocalcemia, coagulopathy, and hemodynamic instability. Through short clinical cases, participants will practice prescribing and troubleshooting TPE at the bedside. By the end of this station, participants will be able to: 1. Explain the pharmacokinetic basis of TPE and justify the prescribed exchange volume and frequency. 2. Select appropriate ASFA-supported indications for TPE in pediatric AKI/critical-care settings and distinguish TPE from CRRT modalities. 3. Prescribe TPE for a child—vascular access, replacement fluid, anticoagulation—and adjust for body size. 4. Recognize and manage common complications (hypocalcemia, coagulopathy, hypotension, reactions).
Station 1 The Critical Initiation: Circuit Priming & Hemodynamic Management

Ting-Yuan Chang Speaker The Critical Initiation: Circuit Priming & Hemodynamic ManagementThis workshop addresses the critical first steps of initiating continuous kidney replacement therapy (CKRT) in pediatric patients. Topics include selecting an appropriate CKRT machine, determining hemofilter size, and designing the extracorporeal circuit. Special emphasis is placed on preventing hemodynamic instability during blood priming and circuit initiation, including calculation of the patient's circulating blood volume relative to the extracorporeal volume to avoid hypovolemic shock from excessive extracorporeal blood sequestration. Participants will learn practical decision-making frameworks for safe circuit priming strategies tailored to children of different body sizes.

Room 2